Previous 10 | Next 10 |
Image source: The Motley Fool. ICON (NASDAQ: ICLR) Q4 2019 Earnings Call Feb 20, 2020 , 9:00 a.m. ET Operator Continue reading
ICON PLC (ICLR) Q4 2019 Earnings Conference Call February 20, 2020, 09:00 ET Company Participants Jonathan Curtain - VP, Corporate Finance & IR Brendan Brennan - CFO Steven Cutler - CEO & Director Conference Call Participants Erin Wright - Crédit Suisse Patri...
Icon (NASDAQ: ICLR ): Q4 Non-GAAP EPS of $1.83 in-line; GAAP EPS of $1.76 misses by $0.07 . More news on: ICON Public Limited Company, Earnings news and commentary, Healthcare stocks news, Read more ...
Acquisition expands ICON’s global Medical Device and Diagnostic Research Services ICON plc , (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device industries, today announced that it h...
Highlights Net business wins in the quarter of $930 million; a book to bill of 1.28. Full year net business wins of $3.6 billion, a net book to bill of 1.30. Record closing backlog of $8.6 billion, an increase of 11.4% year on year. Quarter 4 reported revenue of $725.4 million...
Icon (NASDAQ: ICLR ) is scheduled to announce Q4 earnings results on Wednesday, February 19th, after market close. The consensus EPS Estimate is $1.83 (+13.0% Y/Y) and the consensus Revenue Estimate is $734.13M (+8.1% Y/Y). Over the last 2 years, ICLR has beaten EPS estimates 75% of ...
The following slide deck was published by ICON Public Limited Company in conjunction with this Read more ...
Highlights Full Year 2020 Revenue guidance in the range of $2,972 - $3,092 million, representing growth of 5.8 – 10.0%. Full Year 2020 Earnings per share guidance in the range of $7.55 - $7.85, representing growth of 9.7 – 14.1%. Guidance includes intention to r...
ICON plc , (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations, today announced that Dr. Steve Cutler, CEO and Mr. Brendan Brennan, CFO of ICON plc, will...
Agilent (NYSE: A ) initiated with Overweight rating and $100 (18% upside) price target at Wells Fargo. More news on: Agilent Technologies, Inc., Avantor, Inc., Axonics Modulation Technologies, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Highlights Net business wins in the quarter of $2,579 million, an increase of 6.6% on quarter two 2023. Reflects a net book to bill in the quarter of 1.22, and a trailing twelve month net book to bill of 1.24. Closing backlog of $23.8 billion, an increase of 2.0% on quarter one 20...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that all resolutions at the Annual General Meeting of the company (AGM) held on July 23, 2024 were duly passed by shareholders. ICON also confirmed that following the conclus...
ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2024 with a number of leading business and industry awards recognising the company’s leadership position in the clinical research industry, in addi...